Clinical trial
Translational Studies on Electronic Cigarette-derived Oxidants and Their Long-term Cardiopulmonary Effects
NCT05239793 is registered in ClinicalTrials.gov with Milton S. Hershey Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Translational Studies on Electronic Cigarette-derived Oxidants and Their Long-term Cardiopulmonary Effects
- Lead sponsor
- Milton S. Hershey Medical Center
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- November 22, 2022
- Completion date
- June 30, 2026
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic obstructive pulmonary disease